GlaxoSmithKline has decided a new target with Vodafone: to boost the uptake of childhood vaccinations in Africa with the help of some new innovative mobile technologies.

Yes, the new alliance has been initiated by the drug giant and the famous mobile technology company Vodafone with a belief that their partnership will soon bring out the effects and the country will cite a respite in the number of children taking vaccinations against several infectious diseases.

It has been estimated by the experts that worldwide, a fifth of children are still not able to get their basic vaccination doses.

"The proliferation of mobile phones in Africa offers an opportunity to create innovative and cost-effective ways to address barriers to universal vaccination", the firm said, explaining the rationale for the move.

According to the details provided over the alliance, the companies will be initially focusing upon their one-year project in Mozambique, which has been started with the support of Save The Children and the country's Ministry of Health under which, the companies have planned to inform the mothers through SMS about the availability and importance of immunization services on offer in the region.

Moreover, they have also decided to provide health workers with smart phones containing software to make it easy for them to get in touch with maximum number of mothers, and get to know their view and record vaccination histories, and schedule vaccinations.